These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 27347147)

  • 21. Emodin and Its Combination with Cytarabine Induce Apoptosis in Resistant Acute Myeloid Leukemia Cells in Vitro and in Vivo.
    Chen Y; Gan D; Huang Q; Luo X; Lin D; Hu J
    Cell Physiol Biochem; 2018; 48(5):2061-2073. PubMed ID: 30099447
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Glut-1 as a therapeutic target: increased chemoresistance and HIF-1-independent link with cell turnover is revealed through COMPARE analysis and metabolomic studies.
    Evans A; Bates V; Troy H; Hewitt S; Holbeck S; Chung YL; Phillips R; Stubbs M; Griffiths J; Airley R
    Cancer Chemother Pharmacol; 2008 Mar; 61(3):377-93. PubMed ID: 17520257
    [TBL] [Abstract][Full Text] [Related]  

  • 23. TUG1 knockdown enhances adriamycin cytotoxicity by inhibiting glycolysis in adriamycin-resistant acute myeloid leukemia HL60/ADR cells.
    Chen L; Zhao H; Wang C; Hu N
    RSC Adv; 2019 Apr; 9(19):10897-10904. PubMed ID: 35515331
    [TBL] [Abstract][Full Text] [Related]  

  • 24. FGFR4 Links Glucose Metabolism and Chemotherapy Resistance in Breast Cancer.
    Xu M; Chen S; Yang W; Cheng X; Ye Y; Mao J; Wu X; Huang L; Ji J
    Cell Physiol Biochem; 2018; 47(1):151-160. PubMed ID: 29763898
    [TBL] [Abstract][Full Text] [Related]  

  • 25. WYE-354 restores Adriamycin sensitivity in multidrug-resistant acute myeloid leukemia cell lines.
    Ibrahim SM; Bakhashab S; Ilyas AM; Pushparaj PN; Karim S; Khan JA; Abuzenadah AM; Chaudhary AG; Al-Qahtani MH; Ahmed F
    Oncol Rep; 2019 Jun; 41(6):3179-3188. PubMed ID: 30942458
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [MicroRNA-10a expression in FAB different subtype of acute myeloid leukemia and its relationship with drug resistance].
    Zhi YJ; Zhi F; Wang R; Xue L; Gu WY; Wang B; Dong WM; Li HQ; Ling Y; Qiu GQ; Wang ZL; Cao XS; Liu Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Feb; 23(1):29-33. PubMed ID: 25687041
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Biological properties and sensitivity to induction therapy of differentiated cells expressing atypical immunophenotype in acute leukemia of children].
    Pituch-Noworolska A
    Folia Med Cracov; 2001; 42(3):5-80. PubMed ID: 12353422
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Knockdown of Long Noncoding RNA HOXA-AS2 Suppresses Chemoresistance of Acute Myeloid Leukemia via the miR-520c-3p/S100A4 Axis.
    Dong X; Fang Z; Yu M; Zhang L; Xiao R; Li X; Pan G; Liu J
    Cell Physiol Biochem; 2018; 51(2):886-896. PubMed ID: 30466095
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Wortmannin influences hypoxia-inducible factor-1 alpha expression and glycolysis in esophageal carcinoma cells.
    Zeng L; Zhou HY; Tang NN; Zhang WF; He GJ; Hao B; Feng YD; Zhu H
    World J Gastroenterol; 2016 May; 22(20):4868-80. PubMed ID: 27239113
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversal of chemoresistance with small interference RNA (siRNA) in etoposide resistant acute myeloid leukemia cells (HL-60).
    Kachalaki S; Baradaran B; Majidi J; Yousefi M; Shanehbandi D; Mohammadinejad S; Mansoori B
    Biomed Pharmacother; 2015 Oct; 75():100-4. PubMed ID: 26463638
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Repression of oxidative phosphorylation sensitizes leukemia cell lines to cytarabine.
    Yucel B; Sonmez M
    Hematology; 2018 Jul; 23(6):330-336. PubMed ID: 29139328
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Clinical significance of CD95, Bcl-2 and Bax expression and CD95 function in adult de novo acute myeloid leukemia in context of P-glycoprotein function, maturation stage, and cytogenetics.
    Wuchter C; Karawajew L; Ruppert V; Büchner T; Schoch C; Haferlach T; Ratei R; Dörken B; Ludwig WD
    Leukemia; 1999 Dec; 13(12):1943-53. PubMed ID: 10602414
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [MiR-199a-5p Affects Sensitivity of Acute Myeloid Leukemia to Adriamycin by Targeting DRAM1].
    Li Y; Sun Y; Miao M; Shi X; Yang W; Liu ZG
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2020 Aug; 28(4):1096-1104. PubMed ID: 32798383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Simultaneous suppression of multidrug resistance and antiapoptotic cellular defense induces apoptosis in chemoresistant human acute myeloid leukemia cells.
    Wang X; Wang C; Qin YW; Yan SK; Gao YR
    Leuk Res; 2007 Jul; 31(7):989-94. PubMed ID: 17067671
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Palliative chemotherapy followed by methylation inhibitor in high-risk acute myeloid leukemia: An
    Ding B; Wang Z; Jiang X; Li X; Wang C; Zhong Q; Jiang L; Dai M; Zhang YU; Wei QI; Meng F
    Mol Clin Oncol; 2015 Sep; 3(5):1139-1144. PubMed ID: 26623066
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HOTAIRM1 knockdown enhances cytarabine-induced cytotoxicity by suppression of glycolysis through the Wnt/β-catenin/PFKP pathway in acute myeloid leukemia cells.
    Chen L; Hu N; Wang C; Zhao H
    Arch Biochem Biophys; 2020 Feb; 680():108244. PubMed ID: 31904363
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Glucose Metabolism as a Potential Therapeutic Target in Cytarabine-Resistant Acute Myeloid Leukemia.
    Pereira-Vieira J; Weber DD; Silva S; Barbosa-Matos C; Granja S; Reis RM; Queirós O; Ko YH; Kofler B; Casal M; Baltazar F
    Pharmaceutics; 2024 Mar; 16(4):. PubMed ID: 38675105
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting SLUG sensitizes leukemia cells to ADR-induced apoptosis.
    Wei CR; Liu J; Yu XJ
    Int J Clin Exp Med; 2015; 8(12):22139-48. PubMed ID: 26885188
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Glycolytic inhibitor 2-deoxy-d-glucose suppresses cell proliferation and enhances methylprednisolone sensitivity in non-Hodgkin lymphoma cells through down-regulation of HIF-1α and c-MYC.
    Pang YY; Wang T; Chen FY; Wu YL; Shao X; Xiao F; Huang HH; Zhong H; Zhong JH
    Leuk Lymphoma; 2015 Jun; 56(6):1821-30. PubMed ID: 25219592
    [TBL] [Abstract][Full Text] [Related]  

  • 40. MicroRNA-124 suppresses proliferation and glycolysis in non-small cell lung cancer cells by targeting AKT-GLUT1/HKII.
    Zhao X; Lu C; Chu W; Zhang B; Zhen Q; Wang R; Zhang Y; Li Z; Lv B; Li H; Liu J
    Tumour Biol; 2017 May; 39(5):1010428317706215. PubMed ID: 28488541
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.